FDAnews
www.fdanews.com/articles/179841-avacen-medical-nabs-ce-mark-for-avacen-100

Avacen Medical Nabs CE Mark for Avacen 100

December 28, 2016

Avacen Medical has gained a CE Mark for its Avacen 100 for treatment of patients with pain associated with fibromyalgia.

Avacen 100 is used by noninvasively infusing heat into the circulatory system to create muscular relaxation while increasing microcirculation throughout the body.

The Avacen 100 is not for sale in the U.S. or EU for any non-cleared or non-approved indications. — Cynthia Jessup

View today's stories